These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 23567304)
61. Impaired systemic vascular reactivity & raised high-sensitivity C reactive protein levels in chronic obstructive pulmonary disease. Khare P; Talwar A; Chandran D; Guleria R; Jaryal AK; Kumar G; Trivedi A; Deepak KK Indian J Med Res; 2016 Feb; 143(2):205-12. PubMed ID: 27121518 [TBL] [Abstract][Full Text] [Related]
62. Does systemic inflammation trigger local exercise-induced oxidative stress in COPD? Koechlin C; Couillard A; Cristol JP; Chanez P; Hayot M; Le Gallais D; Préfaut C Eur Respir J; 2004 Apr; 23(4):538-44. PubMed ID: 15083751 [TBL] [Abstract][Full Text] [Related]
63. Exercise alleviates depression related systemic inflammation in chronic obstructive pulmonary disease patients. Abd El-Kader SM; Al-Jiffri OH Afr Health Sci; 2016 Dec; 16(4):1078-1088. PubMed ID: 28479901 [TBL] [Abstract][Full Text] [Related]
64. [Systemic inflammation and atherosclerosis of common carotid arteries in patients with chronic obstructive pulmonary disease]. Chicherina EN; Miliutina OV Klin Med (Mosk); 2009; 87(2):18-20. PubMed ID: 19348294 [TBL] [Abstract][Full Text] [Related]
65. The association of low bone mineral density with systemic inflammation in clinically stable COPD. Liang B; Feng Y Endocrine; 2012 Aug; 42(1):190-5. PubMed ID: 22198912 [TBL] [Abstract][Full Text] [Related]
66. Mechanism of statin-associated mortality reduction in COPD. Hurst JR; Hagan G; Wedzicha JA Chest; 2007 Oct; 132(4):1409; author reply 1409-10. PubMed ID: 17934133 [No Abstract] [Full Text] [Related]
67. The specific features of free radical oxidation in patients with chronic obstructive pulmonary disease and arterial hypertension. Marushchak M; Maksiv K; Krynytska I Pol Merkur Lekarski; 2019 Sep; 47(279):95-98. PubMed ID: 31557137 [TBL] [Abstract][Full Text] [Related]
68. Increased Serum Romo1 Was Correlated with Lung Function, Inflammation, and Oxidative Stress in Chronic Obstructive Pulmonary Disease. Ye L; Mao S; Fang S; Zhang J; Tan Y; Gu W Inflammation; 2019 Oct; 42(5):1555-1560. PubMed ID: 31049771 [TBL] [Abstract][Full Text] [Related]
69. Effects of oxygen therapy on systemic inflammation and myeloperoxidase modified LDL in hypoxemic COPD patients. Zouaoui Boudjeltia K; Tragas G; Babar S; Moscariello A; Nuyens V; Van Antwerpen P; Gilbert O; Ducobu J; Brohee D; Vanhaeverbeek M; Van Meerhaeghe A Atherosclerosis; 2009 Aug; 205(2):360-2. PubMed ID: 19230893 [No Abstract] [Full Text] [Related]
70. [Reactive C protein as a marker of inflammation in patients with arterial hypertension]. Alonso-Rodríguez D; Moreno-Téllez E; Alarcón-Martínez Y; Pedroso-Filiberto E Rev Med Inst Mex Seguro Soc; 2011; 49(3):345-7. PubMed ID: 21839006 [TBL] [Abstract][Full Text] [Related]
71. Is systemic inflammation responsible for pulmonary hypertension in COPD? Sin DD; Man SF Chest; 2006 Aug; 130(2):310-2. PubMed ID: 16899824 [No Abstract] [Full Text] [Related]
72. [Serum markers of inflammation and lipid-releasing ability of leukocytes in patients with arterial hypertension and angina of effort]. Mishlanov VIu; Vladimirskii VE; Syromiatnikova LI; Polovinkina TA; Mishlanova SL Klin Med (Mosk); 2013; 91(11):34-8. PubMed ID: 25696963 [TBL] [Abstract][Full Text] [Related]
73. Chronic Obstructive Pulmonary Disease, inflammation and co-morbidity--a common inflammatory phenotype? Sevenoaks MJ; Stockley RA Respir Res; 2006 May; 7(1):70. PubMed ID: 16669999 [TBL] [Abstract][Full Text] [Related]
74. No TWEAK for COPD. Lazaar AL; Miller BE; Francombe G; Duvoix A; Natanek SA; Polkey MI Eur Respir J; 2013 Oct; 42(4):1142-4. PubMed ID: 24081764 [No Abstract] [Full Text] [Related]
75. [PROINFLAMMATORY CYTOKINES IN COMBINATION OF CORONARY HEART DISEASE AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE]. Provotorov VM; Budnevskiĭ AV; Semenkova GG; Shishkina ES Klin Med (Mosk); 2015; 93(2):5-9. PubMed ID: 26117912 [TBL] [Abstract][Full Text] [Related]
77. [CLINICAL AND PATHOGENETIC PECULIARITIES OF DEVELOPMENT OF ENDOTHELIAL DYSFUNCTION]. Mamaeva MG; Demko IV; Salmina AB; Sobko EA; Malinovskaya NA; Kraposhina A Yu ; Gordeeva NV; Solov'eva IA Klin Med (Mosk); 2016; 94(2):113-20. PubMed ID: 27459760 [TBL] [Abstract][Full Text] [Related]
78. [Clinical and functional characteristics of chronic obstructive pulmonary disease in association with pathology of the cardiovascular system in persons of advanced age]. Avramenko LP; Gurova NA; Kuimova ZhV; Bolotnova TV Adv Gerontol; 2009; 22(4):667-70. PubMed ID: 20405737 [TBL] [Abstract][Full Text] [Related]
79. Systemic inflammation and inhaled corticosteroids in COPD. Antoniu SA Am J Respir Crit Care Med; 2009 Jan; 179(2):170; author reply 170-1. PubMed ID: 19119152 [No Abstract] [Full Text] [Related]
80. Interleukin-6: a red herring or a real catch in COPD? Sin DD; Man SF Chest; 2008 Jan; 133(1):4-6. PubMed ID: 18187736 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]